WCM26: Advances and Applications in Chronic Spontaneous Urticaria Care
Released on
February 13, 2026
WCM26: Advances and Applications in Chronic Spontaneous Urticaria Care
This activity is supported by educational grants from Novartis Pharmaceutical Corporation and Sanofi and Regeneron Pharmaceuticals, Inc.